Moon Surgical raises $55.4M to support surgical robot platform, names Fred Moll board chair

The Maestro surgical robot. [Image courtesy of Moon Surgical]Moon Surgical announced today that it raised $55.4 million and appointed a surgical robotics veteran as the chair of its board.

The French-American company develops the Maestro system to support surgeons in soft tissue surgical procedures. The platform acts as a robotic surgical assistant to augment the precision and control of laparoscopic surgery.

Moon Surgical’s small, adaptable system can integrate into existing clinical workflows. It features capabilities that bolster operating room efficiency and allow for alternative labor models.

The company earmarked its latest fundraising to support the continued development and planned commercialization for Maestro. Moon Surgical received FDA 510(k) clearance for Maestro in December 2022, followed by CE mark last month. In June 2022, Moon Surgical completed a $31.3 million Series A fundraising.

Sofinnova Partners co-led …

Read more
  • 0

Surgical robotics trends and how to accelerate adoption

Moon Surgical Chief Strategy Officer Jeffery Alvarez. [Photo courtesy of Moon Surgical]

Some of the biggest names in the development of surgical robotics systems and virtual reality training technology discussed robotic surgery trends at DeviceTalks Boston.

Moon Surgical Chief Strategy Officer Jeffery Alvarez, Stryker Digital, Robotics, and Enabling Technologies President Robert Cohen, Osso VR CEO Justin Barad and FundamentalVR CEO and co-founder Richard Vincent see rapid changes ahead for surgical robotics and opportunities to win over surgeons, health systems and patients.

We’ve curated excerpts from the conversation, lightly edited for clarity and space.

Trends in surgical robotics

Alvarez: “There’s a transition from building robots that are hyper-specialized in one thing and do one thing really well, to platforms that are looking at how to solve bigger parts of the problem: H…

Read more
  • 0

How these engineers make DeviceTalks Boston go!

We love engineers of all types — here are a just a few you’ll meet at DeviceTalks Boston.

We love engineers here at DeviceTalks.

It’s obvious why. Engineers are the straw that stirs medtech’s drink (apologies to Reggie Jackson). Nothing happens — financing, manufacturing, approval, help for patients — without a well-conceived product.

And engineers often transcend their typical design roles. They grow into business leaders, technology evangelists, startup CEOs, and yes, some stay to lead ground-breaking research and development groups.

So I’m thrilled to be bringing engineers of all types into the agenda of DeviceTalks Boston. We’ll have engineers from Abbott, ZimVie, Philips, Boston Scientific, Stryker and many other companies on hand to talk about being an engineer.

But we’ll also hear from engineers who have followed their careers into other parts of the medical device industry.

In this column, we’ll walk you through some of their …

Read more
  • 0

Moon Surgical completes first-in-human clinical study of surgical robot

The Maestro surgical robot. [Image courtesy of Moon Surgical]Moon Surgical announced today that it successfully completed 30 first-in-human laparoscopy procedures with its Maestro surgical robot.

It marks more good news for the French company, which last week won FDA clearance for Maestro. The clearance offers support to surgeons in soft tissue surgical procedures.

Moon Surgical designed Maestro for soft tissue procedures not currently supported by telerobotic systems. The small, adaptable system can integrate into existing clinical workflows and provide the surgeon with more control.

The Maestro system also increases operating room efficiency by enhancing surgical instruments and techniques. It also minimizes the impact on operating room turnover time, according to a news release.

Dr. Guy-Bernard Cadière performed all 30 procedures. They took place at CHU Saint-Pierre, a public university hospital in Brussels, Belgium.

“I am thrilled to…

Read more
  • 0

Moon Surgical wins first FDA 510(k) clearance for surgical robot

This screen grab from a Moon Surgical marketing video gives an idea of what the Maestro robotic surgery system looks like in action [Image courtesy of Moon Surgical]Moon Surgical announced today that it received FDA 510(k) clearance for its Maestro surgical robotics system.

Paris- and San Francisco-based Moon Surgical designed Maestro to support surgeons in soft tissue surgical procedures. Think of it as a robotic surgical assistant.

The small, adaptable system can integrate into existing clinical workflows. It features capabilities that bolster operating room efficiency and allow for alternative labor models, the company said.

In June, Moon Surgical completed a $31.3 million Series A fundraising. CEO Ann Osdoit said the company aims to make Maestro capable of use in any laparoscopy in any operating room. This could revolutionize minimally invasive surgery through collaborative and adaptive robotics.

Moon Surgical featured…

Read more
  • 0

16 surgical robotics companies you need to know

Intuitive remains the dominant surgical robotics company, but corporations ranging from Medtronic to Vicarious Surgical look to compete. The Da Vinci Xi robotic surgery system. Intuitive continues to dominate the space. [Image courtesy of Intuitive]Robotic-assisted surgery remains one of the hottest spaces in medtech. Intuitive, which pioneered the field in the 1990s and early 2000s, continues to innovate. At the same time, a host of other companies are looking to compete.

Companies making headlines in the robotic surgery space over the past year include:

Company Robotic system(s) Intuitive Surgical Da Vinci Xi, Da Vinci X, Da Vinci SP, Ion Medtronic Hugo Johnson & Johnson Monarch, Velys, Ottava Stryker Mako Siemens Healthineers’ Corindus CorPath GRX Vicarious Surgical Beta 2 Titan Medical Enos Asensus Surgical Senhance Moon Surgical Maestro Momentus Surgical Anovo Virtual Incision MIRA Stereotaxis Genesis RMN, Vdrive, Niobe Monteris …
Read more
  • 0

Moon Surgical raises $31.3M for robotic surgery system

Moon Surgical (Paris and San Francisco) announced today that it has raised $31.3 million in Series A funding to expand its team and accelerate the development of its Maestro robotic surgery system.

GT Healthcare Capital & Partners led the round. There was also participation from  Johnson & Johnson Innovation – JJDC, Cathay Health — and existing investors including Sofinnova Partners and medtech leaders including Yann Fleureau, Siddarth Satish, Sacha Loiseau and Richard Leparmentier.

“At Moon Surgical, our ambition is to revolutionize minimally invasive surgery through the power of collaborative and adaptive robotics. Our Maestro System can be used in any laparoscopy, in any operating room,” said Anne Osdoit, CEO of Moon Surgical and a partner in Sofinnova Partners’ medtech accelerator, MD Start.

“We are excited to work with our new partners at GT Healthcare, Johnson & Johnson, and Cathay Health as we enter the ne…

Read more
  • 0